Richard Dodel

9.6k total citations
30 papers, 450 citations indexed

About

Richard Dodel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Richard Dodel has authored 30 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Neurology. Recurrent topics in Richard Dodel's work include Alzheimer's disease research and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Richard Dodel is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Richard Dodel collaborates with scholars based in Germany, United States and Norway. Richard Dodel's co-authors include Monika Balzer‐Geldsetzer, Jan‐Philipp Bach, Michael Bacher, Bernhard Meyer, Oliver Deuster, Jens‐Peter Reese, Frank Schneider, Wolfgang H. Oertel, Amalia M. Dolga and Astrid Althaus and has published in prestigious journals such as Journal of Biological Chemistry, Cancer and Scientific Reports.

In The Last Decade

Richard Dodel

29 papers receiving 436 citations

Peers

Richard Dodel
Stephen Trevick United States
Susan E. Libretto United Kingdom
Mona Shahriari United States
N. Collins United States
Stephen Trevick United States
Richard Dodel
Citations per year, relative to Richard Dodel Richard Dodel (= 1×) peers Stephen Trevick

Countries citing papers authored by Richard Dodel

Since Specialization
Citations

This map shows the geographic impact of Richard Dodel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Dodel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Dodel more than expected).

Fields of papers citing papers by Richard Dodel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Dodel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Dodel. The network helps show where Richard Dodel may publish in the future.

Co-authorship network of co-authors of Richard Dodel

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Dodel. A scholar is included among the top collaborators of Richard Dodel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Dodel. Richard Dodel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dodel, Richard & Lutz Froelich. (2025). Donanemab for Alzheimer’s disease: from preclinical research to the clinical application. Expert Review of Neurotherapeutics. 25(10). 1151–1163. 3 indexed citations
2.
Brandts, Christian, Hannah Dinse, Eva‐Maria Skoda, et al.. (2025). Consequences of COVID-19 for geriatric patients during a pandemic. Scientific Reports. 15(1). 3136–3136. 1 indexed citations
3.
Maetzler, Walter, Richard Dodel, & Andréas H. Jacobs. (2018). Neurogeriatrie. 4 indexed citations
4.
Gold, Maike, et al.. (2016). Synthesis of a biological active β-hairpin peptide by addition of two structural motifs. Bioorganic & Medicinal Chemistry. 25(2). 603–608. 10 indexed citations
5.
Dodel, Richard, et al.. (2015). SK channel activation modulates mitochondrial respiration and attenuates neuronal HT-22 cell damage induced by H2O2. Neurochemistry International. 81. 63–75. 28 indexed citations
6.
Gold, Maike, Amalia M. Dolga, Janine Koepke, et al.. (2014). α 1-antitrypsin modulates microglial-mediated neuroinflammation and protects microglial cells from amyloid-β-induced toxicity. Journal of Neuroinflammation. 11(1). 165–165. 39 indexed citations
7.
Dodel, Richard, et al.. (2013). Synthetic Dimeric Aβ(28–40) Mimics the Complex Epitope of Human Anti-Aβ Autoantibodies against Toxic Aβ Oligomers. Journal of Biological Chemistry. 288(38). 27638–27645. 9 indexed citations
8.
Hamer, Hajo M., Richard Dodel, Adam Strzelczyk, et al.. (2012). Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany—a nationwide population-based study in children and adults. Journal of Neurology. 259(11). 2376–2384. 101 indexed citations
9.
Deuster, Oliver, Carmen Noelker, Carsten Stüer, et al.. (2011). Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells. Journal of Neuroscience Research. 89(5). 711–717. 33 indexed citations
10.
Voigt-Radloff, Sebastian, Maud Graff, Rainer Leonhart, et al.. (2011). A multicentre RCT on community occupational therapy in Alzheimer's disease: 10 sessions are not better than one consultation. BMJ Open. 1(1). e000096–e000096. 45 indexed citations
12.
Bach, Jan‐Philipp, David Mengel, Tina Wahle, et al.. (2011). P2‐444: The Role of CNI‐1493 in the function of primary microglia with respect to β‐Amyloid. Alzheimer s & Dementia. 7(4S_Part_13). 1 indexed citations
13.
Bach, Jan‐Philipp, David Mengel, Tina Wahle, et al.. (2011). The Role of CNI-1493 in the Function of Primary Microglia with Respect to Amyloid-β. Journal of Alzheimer s Disease. 26(1). 69–80. 21 indexed citations
14.
Reese, Jens Peter, Yaroslav Winter, Sonja von Campenhausen, et al.. (2011). Estudio de cohortes sobre la carga socioeconómica de la enfermedad de Parkinson en Portugal. Revista de Neurología. 52(5). 264–264. 7 indexed citations
15.
Gu, Huiying, Xing Wei, Richard Dodel, et al.. (2010). P1‐232: Lead exposure induces beta‐amyloid accumulation and inhibits LRP1 expression in APP transgenic mice. Alzheimer s & Dementia. 6(4S_Part_8). 1 indexed citations
16.
Bach, Jan‐Philipp, Oliver Deuster, Monika Balzer‐Geldsetzer, et al.. (2009). The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors. Cancer. 115(10). 2031–2040. 69 indexed citations
17.
Schneider, Frank, Astrid Althaus, Volker Backes, & Richard Dodel. (2008). Psychiatric symptoms in Parkinson’s disease. European Archives of Psychiatry and Clinical Neuroscience. 258(S5). 55–59. 35 indexed citations
18.
Eggert, Karla, H. Baas, Günther Deuschl, et al.. (2007). Das Kompetenznetz Parkinson. Nervenheilkunde. 26(4). 239–240. 2 indexed citations
19.
Wei, Xing, Xianming Chen, Christine V. Fontanilla, et al.. (2006). C/T conversion alters interleukin-1A promoter function in a human astrocyte cell line. Life Sciences. 80(12). 1152–1156. 10 indexed citations
20.
Eggert, Karla, H. Baas, Günther Deuschl, et al.. (2005). Das Kompetenznetz Parkinson. e-Neuroforum. 11(4). 130–133. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026